|
There are three types of hypertensive
disorders in pregnancy: chronic hypertension, gestational hypertension
and pre-eclampsia. Hypertension in pregnancy may be defined as an absolute
increase in blood pressure >140/90 mmHg or a relative rise in blood pressure
in either systolic pressure >30 mmHg or diastolic pressure >15 mmHg above
blood pressure at pre-natal booking.
Chronic hypertension should
be diagnosed in a patient who has a known history of hypertension before
pregnancy or if the hypertension occurred before 20 weeks' gestation.
Gestational hypertension occurs
in the second half of pregnancy and resolves by 6 weeks post partum.
Pre-eclampsia is defined as
gestational hypertension with >0.3 g proteinuria per 24 hours. Oedema
is not essential as it is a non-specific finding.
Most physicians would start
treatment if blood pressure is >140/90 mmHg. In general, apart from angiotensin
converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB),
most conventional anti-hyper- tensive drugs are not fetotoxic or contraindicated
in pregnancy. The first-line drug of choice remains to be methyldopa,
which is a centrally acting agent with a long safety record in pregnancy.
Its sedative side effect sometimes limits its application and it may cause
increases in liver enzymes or a positive Coomb's test. It should be avoided
in women with a prior history of depression and after delivery, preferably
it should be changed to other drugs if possible to decrease the risk of
post-partum depression.
Second-line drugs include
nifedipine and hydralazine and third-line drugs include beta blockers
and thiazide diuretics. Beta blockers have concerns of growth restriction
and thiazides might cause plasma volume contraction, thereby limiting
their use to third line in general. After delivery, however, a beta blocker
is often the drug of first choice for blood pressure control.
|